No Data
Truist Financial Maintains IGM Biosciences(IGMS.US) With Buy Rating, Announces Target Price $24
All You Need to Know About IGM Biosciences (IGMS) Rating Upgrade to Buy
Express News | IGM Biosciences Shares Are Trading Higher. JP Morgan Raised Its Price Target on the Stock From $11 to $12
Wedbush Maintains IGM Biosciences(IGMS.US) With Buy Rating, Raises Target Price to $25
Analysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS)
IGM Biosciences Is Maintained at Neutral by JP Morgan